← Back to all signals
RESEARCH PAPER ANALYSIS

Sex differences in urinary mast cell mediators: Implications for diagnosing atopic and mast cell disorders.

AI interpretation is pending for this paper.

Open original publication →
PMID40480425
JournalAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Publication Date2025-06-04
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Urinary mast cell mediators aid in diagnosing atopic and mast cell disorders, yet sex differences in these mediators remain unreported despite known sex-specific variations in eicosanoid pathways. OBJECTIVE: To characterize sex differences in urinary mast cell mediators 2,3-dinor-11β-prostaglandin F2α (2,3-BPG), N-methylhistamine, and leukotriene E4 (LTE4). METHODS: This retrospective chart review of 4033 patients of all ages at Mayo Clinic from June 1, 2019 to May 31, 2024 including demographic and clinical data. Urine mast cell mediators 2,3-BPG, N-methylhistamine, and LTE4 were quantified using liquid chromatography-tandem mass spectrometry and normalized to creatinine levels. Statistical analyses were performed using R software (R Core Team, Vienna, Austria). RESULTS: Among patients tested for urinary mast cell mediators, 78.8% were female sex. Compared with females, males were older at testing (mean 48.0 vs 40.1 years), more likely to report ever smoking (33.5% vs 22.7%), had higher body mass index (mean 28.6 vs 27.7), more often had an atopic condition (82.6% vs 71.0%) or comorbidity (46.1% vs 30.3%), and had higher median LTE4 levels (102.5 vs 90.0 pg/mg creatinine) (P < .001 for all). Males also more typically had elevated 2,3-BPG (8.0% vs 3.7%) and eosinophil counts (17.0% vs 5.9%) and higher median tryptase levels (5.1 vs 4.3 pg/mL) (P < .001 for all). Multivariable analysis revealed a sex-by-atopy interaction for LTE4, with higher levels in atopic males (male/female ratio 1.15 [95% CI: 1.07-1.25], P < .001) and higher levels in nonatopic females (male/female ratio 0.86 [95% CI: 0.76-0.97], P = .02). CONCLUSION: Sex differences in testing rates and urinary mediator levels highlight the need to consider sex in optimizing the diagnostic utility of these mediators.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Molecular diagnostics in paediatric oncology in Latin America: findings from the Latin America Regional Advisory Committee (RAC LATAM) regional assessment. Ecancermedicalscience 54.0 2 PEDCan: acceptability and feasibility of a mobile application to support primary health-care workers in recognising clinical features of childhood cancer in Uganda. Ecancermedicalscience 59.0 3 Li-Fraumeni Syndrome: Current Perspectives on Molecular Pathogenesis, Surveillance Strategies, Clinical Management and Pediatric Considerations. Cureus 82.5 4 Mechanism-Driven Evolution of Fertility-Sparing Treatment and Precision Management of Special Populations in Endometrial Cancer: A Review. Cancers 85.09 5 Exposure to Particulate Matter (PM) During Pregnancy and Non-Hodgkin Lymphomas in Children. Cancers 69.5 6 Whole-Body MRI Versus 18F-FDG-PET/CT for the Detection of Nodal and Distant Metastases in Pediatric Patients with Solid Tumors. Cancers 70.9 7 Prehabilitation Practices for Paediatric Haematopoietic Stem Cell Transplantation: A Survey and Patient and Public Involvement Study of Healthcare Professionals. Nutrients 62.2 8 Comparison of Radiological and Postoperative Tumor Volume Measurements for SIOP Risk Stratification in Wilms Tumord. Diagnostics (Basel, Switzerland) 59.9 9 Neurofilament Light Chain: A Potential Biomarker for Chemotherapy-Induced Peripheral Neuropathy in Pediatric and Adolescent Young Adults with Leukemia or Lymphoma. Cancers 73.59 10 Immune Modulation in Peripheral Blood of Cystic Fibrosis Patients Following Ex Vivo Co-Culture with Mesenchymal Stem Cells. Cells 61.2 11 The Gut-Brain Axis and Dietary Patterns in Shaping Long-Term Neurocognitive and Psychosocial Outcomes in Adolescent and Young Adult Survivors of Childhood Cancer: A Systematized Narrative Review. Nutrients 85.6 12 Association of Recorded Cerebrospinal Fluid Diversion with Registry Outcome Status in Pediatric Medulloblastoma: An Exploratory 10-Year Single-Centre Cohort Study. Journal of clinical medicine 66.1 13 Changes in Ultrasound-Based Risk Stratification and Surgical Selection of Adnexal Masses During the COVID-19 Pandemic: A Single-Center Retrospective Study. Diagnostics (Basel, Switzerland) 65.4 14 Multi-Target HCC Blood Test Demonstrates Consistent Performance Across Subgroups of Patients with Chronic Liver Disease. Cancers 67.0 15 Pediatric Mycosis Fungoides and Hydroa Vacciniforme Lymphoproliferative Disorder. Cancers 62.3 16 Silent Verb Generation During fMRI Reveals Post-Radiotherapy Alterations in Cerebellar-Cerebral Language Regions in Patients Treated for Medulloblastoma. Cancers 71.24 17 Evaluating the Prognostic Relevance of Pre-Treatment Epstein-Barr Virus Levels in Non-Endemic Pediatric Nasopharyngeal Carcinoma. Cancers 70.34 18 Severe Suprasystemic Refractory Pulmonary Hypertension in a Neonate with Stüve-Wiedemann Syndrome Associated with Biallelic LIFR Variants: Molecular Insights and a Neonatal Case Report. International journal of molecular sciences 51.12 19 Clinical Outcome and Prognostic Factors in Childhood Acute Lymphoblastic Leukemia-A Retrospective Cohort Study of Patients from Southern Mexico. Journal of clinical medicine 70.3 20 Case Report: Single-cell transcriptomic profiling of a pediatric ALK-negative gastric inflammatory myofibroblastic tumor. Frontiers in immunology 45.5 21 Case Report: Mixed gonadal dysgenesis with Müllerian remnants mimicking a prostatic utricle in a child with 45,X/46,XY/47,XYY mosaicism. Frontiers in pediatrics 49.0 22 Sodium fluorescein in pediatric brain tumor surgery: a retrospective volumetric analysis of resection extent and consistency. Frontiers in surgery 56.0 23 Electromagnetic Surgical Navigation for Accurate Pediatric Tumor Localization: A Preclinical Animal Cadaver Study. Cancers 59.6 24 T-lymphoblastic leukemia/lymphoma: a comprehensive review of pathology, molecular features, and differential diagnosis. Journal of pathology and translational medicine 64.0 25 Family Bonds at the End of Life: A Qualitative Study of Meaning Reconstruction Through Intergenerational Relationships Among Older Adults With Advanced Lung Cancer. Psycho-oncology 57.5 26 Scenario-Related Anxiety, Self-Reported Critical Incidents, and Burnout Among Anesthesia Professionals: A Cross-Sectional Survey. Healthcare (Basel, Switzerland) 59.0 27 Research Progress on Angiogenesis and Involution Mechanisms of Infantile Hemangioma and Its Regulation by Active Components of Salvia miltiorrhiza. International journal of molecular sciences 59.75 28 Nutritional Prevention of Oxidative Stress-Induced Cardiotoxicity in Pediatric Cardio-Oncology: Molecular Mechanisms and Translational Perspectives-A Narrative Review. International journal of molecular sciences 72.37 29 Perceived Facilitators and Barriers Inform Young Adult Cancer Survivors' Preferences for Physical Activity and Diet Interventions: A Qualitative Study. Nutrients 62.2 30 Three-Dimensional Left Ventricle Strain Echocardiography in the Detection of Anthracycline Cardiotoxicity in Children with Acute Lymphoblastic Leukemia-Retrospective Case-Control Analysis and Relation to the Cardiotoxicity Risk Factors Assessment. Cancers 70.22 31 Chemotherapy-Mediated Purging Before Testicular Organoid Generation Significantly Reduces Cancer Cells While Not Significantly Reducing Germ Cells. International journal of molecular sciences 63.34 32 Phenotype-Specific Pharmacogenetic Patterns of Methotrexate Neurotoxicity in Pediatric Acute Lymphoblastic Leukemia. Journal of clinical medicine 67.02
PATIENT-FRIENDLY SUMMARY

Sex differences in urinary mast cell mediators: Implications for diagnosing atopic and mast cell disorders.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic